PATERNAL EXPOSURE TIMING UNSPECIFIED

PATERNAL EXPOSURE TIMING UNSPECIFIED was reported 267 times

PATERNAL EXPOSURE TIMING UNSPECIFIED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Opioid Antagonist [EPC] 1 0.0010
1 CD52-directed Cytolytic Antibody [EPC] 11 0.0006
2 Selective T Cell Costimulation Blocker [EPC] 2 0.0004
3 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 3 0.0004
4 Anthelmintic [EPC] 1 0.0003
5 Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] 3 0.0003
6 Pyrimidine Synthesis Inhibitor [EPC] 10 0.0002
7 Paramagnetic Contrast Agent [EPC] 1 0.0002
8 Prostaglandin E1 Analog [EPC] 2 0.0001
9 Cephalosporin Antibacterial [EPC] 1 0.0001
10 Serotonin Reuptake Inhibitor [EPC] 10 0.0001
11 Antimalarial [EPC] 1 0.0001
12 Antiprotozoal [EPC] 1 0.0001
13 Complement Inhibitor [EPC] 4 0.0001
14 Nucleoside Analog Antiviral [EPC] 6 0.0001
15 Oxazolidinone Antibacterial [EPC] 2 0.0001
16 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
17 Topoisomerase Inhibitor [EPC] 4 0.0001
18 Vitamin D3 Analog [EPC] 1 0.0000
19 Antimetabolite Immunosuppressant [EPC] 1 0.0000
20 Recombinant Human Growth Hormone [EPC] 1 0.0000
21 Retinoid [EPC] 11 0.0000
22 Muscle Relaxant [EPC] 2 0.0000
23 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0000
24 Partial Opioid Agonist [EPC] 4 0.0000
25 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 5 0.0000
26 Antimycobacterial [EPC] 1 0.0000
27 Programmed Death Receptor-1 Blocking Antibody [EPC] 4 0.0000
28 Purine Antimetabolite [EPC] 4 0.0000
29 Calcineurin Inhibitor Immunosuppressant [EPC] 5 0.0000
30 Erythropoiesis-stimulating Agent [EPC] 2 0.0000
31 Alkylating Drug [EPC] 9 0.0000
32 Methylxanthine [EPC] 2 0.0000
33 Cholinergic Nicotinic Agonist [EPC] 2 0.0000
34 Antirheumatic Agent [EPC] 3 0.0000
35 Arteriolar Vasodilator [EPC] 2 0.0000
36 Polyene Antifungal [EPC] 1 0.0000
37 Histamine-1 Receptor Antagonist [EPC] 2 0.0000
38 Anti-IgE [EPC] 2 0.0000
39 Central Nervous System Stimulant [EPC] 2 0.0000
40 Aminoglycoside Antibacterial [EPC] 1 0.0000
41 Phosphodiesterase 5 Inhibitor [EPC] 3 0.0000
42 Insulin [EPC] 1 0.0000
43 Interferon beta [EPC] 4 0.0000
44 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
45 Aminosalicylate [EPC] 2 0.0000
46 Thalidomide Analog [EPC] 10 0.0000
47 Interleukin-4 Receptor alpha Antagonist [EPC] 9 0.0000
48 Corticosteroid [EPC] 20 0.0000
49 Atypical Antipsychotic [EPC] 7 0.0000
50 Vitamin B12 [EPC] 5 0.0000
51 Nonsteroidal Anti-inflammatory Drug [EPC] 20 0.0000
52 Prostacycline Vasodilator [EPC] 2 0.0000
53 Expectorant [EPC] 3 0.0000
54 Vitamin D [EPC] 4 0.0000
55 Tumor Necrosis Factor Blocker [EPC] 13 0.0000
56 Angiotensin 2 Receptor Blocker [EPC] 4 0.0000
57 Integrin Receptor Antagonist [EPC] 1 0.0000
58 Amide Local Anesthetic [EPC] 1 0.0000
59 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
60 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
61 Opioid Agonist [EPC] 3 0.0000
62 Antiarrhythmic [EPC] 1 0.0000
63 Interleukin-12 Antagonist [EPC] 1 0.0000
64 Vitamin C [EPC] 4 0.0000
65 Interleukin-23 Antagonist [EPC] 1 0.0000
66 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
67 Mood Stabilizer [EPC] 2 0.0000
68 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
69 Anti-epileptic Agent [EPC] 2 0.0000
70 Fluoroquinolone Antibacterial [EPC] 1 0.0000
71 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
72 Platinum-based Drug [EPC] 2 0.0000
73 Factor Xa Inhibitor [EPC] 2 0.0000
74 Leukocyte Growth Factor [EPC] 1 0.0000
75 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
76 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
77 Thiazide Diuretic [EPC] 1 0.0000
78 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
79 Platelet Aggregation Inhibitor [EPC] 2 0.0000
80 Proton Pump Inhibitor [EPC] 2 0.0000
81 Benzodiazepine [EPC] 2 0.0000
82 GLP-1 Receptor Agonist [EPC] 1 0.0000
83 Insulin Analog [EPC] 1 0.0000